Aims: In the context of often-prolonged hospitalisation following low-trauma hip fracture (LTHF), we sought to determine the feasibility of a targeted hospital-in-the-home program for these patients.
Methods: Prospective, quasi-experimental (consumer-choice) study at a tertiary metropolitan hospital, NSW, Australia. Eligibility: community-dwelling patients with LTHF, 22/7/24-30/11/24, planning rturn to the community. Intervention: a multidisciplinary early supported physical hospital discharge program (HITH4Hips); control: eligible but declined.
Primary feasibility and several secondary outcomes were mapped to elements of the RE-AIM framework: reach (characteristics, eligibility, consent), effectiveness (‘success rate’, length-of-stay [LOS; acute, and physical in-hospital], hospital-acquired complications [HACs], opioid consumption; patient-reported pain control, health-related quality of life [EQ-Today], falls efficacy, experience measures, health service use, medication costs), adoption (acceptability), implementation (carer burden, fidelity).
Results: Amongst 101 patients with LTHF, 32/101 remained HITH-eligible, 22/32 consented, 19 transferred onto HITH4Hips; 10 potentially eligible patients declined HITH4Hips. Overall, 18/19 HITH4Hips patients successfully remained in HITH; one patient experienced a fall, representing to hospital. Overall, 95% (18/19) patients reported HITH4Hips’ quality of treatment and care was good/very good. Carer burden was mostly reported as nil/low.
Mean number of days on HITH4Hips was 5.3 days (95% CI 4.0-6.6), mean difference total LOS (14.4 days, 95% CI 9.1-19.6) and physical ward bed LOS (20 days, 95% CI 14.9-24.8), favouring HITH4Hips. Daily opioid consumption was lower and EQ-Today scores higher amongst HITH patients.
Conclusions: This study met all feasibility thresholds, demonstrating potential reach/adoption/effectiveness/implementation of HITH4Hips for selected patients, supporting the need for large randomised controlled trials of early supported discharge after LTHF.